Novo Nordisk, Sanofi, and Eli Lilly Lead in the $12 Billion U.S. Diabetes Market

News   Jul 15, 2013

 
Novo Nordisk, Sanofi, and Eli Lilly Lead in the $12 Billion U.S. Diabetes Market
 
 
 

RELATED ARTICLES

XenoGesis and Juniper Pharma Services Strengthen Alliance

News

Campanies extend strategic alliance in early drug development services.

READ MORE

Quotient Clinical Signs Cocrystal Agreement with Nuformix

News

Partnership to evaluate cocrystal formulations using translational pharmaceutics.

READ MORE

Quest Diagnostics to Acquire Cleveland HeartLab

News

Cleveland HeartLab to be the base for Quest's first national center of excellence in cardiometabolic disorders, with a focus on services that help patients and physicians nationwide identify hidden risks of heart disease.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE